Cathie Wood of Ark Invest first bought shares of Beam Therapeutics (BEAM 4.14%), a biotech focused on precision genetic ...

Biotechnology companies are coming out of a dark period for the industry. Why has the tide turned and is now a good time to ...

While UK biotech financing recovery is present in the private markets, BIA CEO Chris Molloy notes that UK public sector ...

Biotech remains one of the market's more out-of-favor sectors despite improving industry fundamentals. Here are three stocks trading near multiyear lows.

Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. Adam Feuerstein is a senior writer and ...

Incyte Corporation is a profitable, cash-generating biotech with a robust pipeline and a core revenue driver in Jakafi. Read ...

The Tucson company will use its IPO proceeds to advance trials for NanO2, designed to treat hypoxia after stroke. It would be ...

An American biotech company that specializes in stem cell therapy has been waiting for nearly three years for the Food and ...

The Charlottesville, Va. facility is designed to provide the state's ever-evolving biotechnology industry space to ...

INDIANAPOLIS, Sept. 9, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the launch of Lilly TuneLab, an artificial intelligence and machine learning (AI/ML) platform that ...

MEDDDICAL has announced the launch of a real-world evidence (RWE) advisory service for pharmaceutical and biotech teams ...

Another wave of layoffs has hit one of the Bay Area's biggest biotech companies—and the latest cuts push a troubling trend ...